← Research hub  ·  securities

TRV · Travelers Companies $374.51 -4.98 (-1.31%) 2026-SEP-18 12:48 EST

My allocationNot heldas of 2026-SEP-03 · allocation page ↗
Research: QT · SA · STK · FA6 mentions
2026-SEP-17 · CNBC · CNBC Halftime Report (audio edition, day after the FOMC hike) · Positiveinsight · read ↗ · source page ↗$380.21

In short: In Terranova's insurer list (12:31) — higher rates lift float income; a "building trend" he expects to last into year-end.

SOD $380.21
2026-SEP-07 · Ryan Tunis · The Real Eisman Playbook, Ep 74 (host Steve Eisman) · Positiveinsight · ▶ 27:19 · source page ↗$372.12

In short: Recommended: the early-soft-market winner — a middle-market, agent-based footprint that is "harder to burn your way into," and a reserve position that "impresses me quite a bit more than the other commercial lines underwriters." Knock: a bit expensive at ~12.5x earnings; he disagrees with the recent downgrades.

In plain English

Insurers go through "hard" markets (they can raise prices at will) and "soft" markets (competition forces prices down). After an unusually long seven-year hard market, commercial insurance has turned soft. Tunis's point is that not all insurers feel that equally.

Travelers mostly insures mid-sized businesses through local agents who have relationships built over decades — a newcomer can't simply undercut its way in. It also set aside unusually conservative "reserves" (money held for future claims), which acts as a cushion when prices fall. That is why he prefers it, even though the stock isn't cheap.

27:19that actually allows you to absorb a lot of that rate pressure early on. Correct. Travelers' reserve position

27:27impresses me quite a bit more than the other commercial lines underwriters. Okay. so I feel better about the type of

SOD $372.12 (open 2026-SEP-04)
2026-AUG-06 · CNBC · CNBC Halftime Report (audio edition) · Positiveinsight · read ↗ · source page ↗$385.40

In short: Named in Brown's insurance run — "insurance stocks, we've been highlighting them all year: Travelers, Chubb, Allstate, MetLife, one after another. All of those charts look great" — and part of why he thinks Berkshire's own strength "doesn't look out of place."

SOD $385.40
2026-AUG-03 · David Hay · Haymaker (Substack newsletter, paid) · Neutralinsight · read ↗ · source page ↗$377.08

In short: ★ Today's rating change — moved off the Buy List onto Holds/Trims, rated H (lot 6/26/2026 @ $327.37, marked $373.24, +14.01%). The June-26 POW! quality-compounder pick is up ~14% in five weeks and is now a hold rather than a buy — the "raise cash in richly valued securities" instruction applied to a winner that has run to the top of its re-rating range.

In plain English

Travelers is a big property-and-casualty insurer and was Haymaker's Pick of the Week on June 26 as a quality compounder. Five weeks later it's up about 14% and gets moved off the buy list to Hold. The June case (an insurer earning excellent returns, sitting on a $106 billion bond portfolio that pays more as rates rise, at a cheaper multiple than its peers) hasn't been withdrawn — the stock has simply covered a good chunk of the re-rating he was playing for. Combined with this week's "raise cash in expensive securities" message, the read is: keep it, don't buy more here.

SOD $377.08
2026-JUN-29 · Joe Terranova · CNBC Halftime Report (audio edition) · Positiveinsight · read ↗ · source page ↗$327.00

In short: One of the reasonable-valuation insurers (with Allstate and Chubb) he cites as momentum-sector winners — "all doing really well YTD."

In plain English

Travelers is a major commercial and personal insurer. It's one of the three insurance names (with Allstate and Chubb) Terranova cites as evidence that the momentum factor has spread into reasonably-valued financials — "all doing really well YTD." A way to own momentum without paying growth-stock prices.

SOD $327.00
2026-JUN-26 · David Hay · Haymaker (Substack newsletter, paid) · Positiveinsight · read ↗ · source page ↗$319.99

In short: Pick of the Week — a Buy for long-term compounders. Q1 2026 core EPS $7.71 vs $7.08 est (+9% beat), revenue $11.92B (+7.4%), 19.7% ROE; FY2025 net written premium $43.6B, net income $6.3B (+25.8%), TTM core ROE 22.7%, combined ratio 88.6% / underlying 85.3%. Has repriced its whole book to "rate adequacy." A $106B investment portfolio (90%+ high-quality fixed income) earns a rising tail in a higher-for-longer world ($3.3B after-tax NII guided 2026). Capital return ~20% annualized on a ~$46B cap ($2.2B returned in Q1, dividend +14% — 14th straight year). AI/automation real: >half of claims straight-through, expense ratio −300bp since 2016 (~$430M/yr), $13B tech spend, 65B proprietary data points. ~10.8× NTM P/E vs Chubb 12.3× / Progressive 12.8× despite a higher ROE; re-rate toward ~13× the upside. Barclays cut to Underweight Jun 12 (main bear case) but the stock sits at a 52-week high; a likely ~5% pullback is a more aggressive entry. A long-term hold, not a trade.

In plain English

Travelers is one of America's biggest property-and-casualty insurers — it writes the home, auto, business and specialty policies that pay out when something goes wrong. Two things make Haymaker like it right now. First, "rate adequacy": after years of catastrophe and inflation losses, the company has methodically re-priced almost every policy so the premiums it charges finally match the risks it takes — that's why it earns a 22.7% return on equity (one of the best in the industry) with lots of margin to spare. Second, the "float": insurers collect premiums today and pay claims later, and they invest the cash in between. Travelers sits on a $106 billion mostly-bond portfolio, and in a world where interest rates stay higher for longer, that pile now throws off a growing river of income (guided to $3.3 billion after tax this year) that was earning almost nothing during the zero-rate decade.

On top of that, the company hands shareholders roughly 20% of its market value back every year through dividends and buybacks (it just raised the dividend 14%, the 14th year in a row), yet the stock trades at only ~10.8× next year's earnings — cheaper than rivals Chubb and Progressive even though it out-earns them. Haymaker's view is simple: this is a high-quality "compounder" being priced like a boring, fully-valued utility, and it should drift up toward a ~13× multiple over time. The catch is that one bad hurricane season can dent any quarter, and a Wall Street desk (Barclays) just turned cautious with the stock at a 52-week high — so a ~5% dip is likely, and Haymaker would use it to buy more aggressively. This is a long-term hold to compound with, not a quick trade.

SOD $319.99

Nothing matches this filter.

Verbatim excerpts from the public transcripts (auto-pulled at each mention's timestamp, lightly cleaned). Timestamps link into the video; "source page" opens that commentator's full analysis at this row. Click a mention's header line to expand it (one open at a time). For personal study — not investment advice.